Peter Eickelmann
Impact in
-
- Diabetes Treatment and Management
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Genomics, phytochemicals, and oxidative stress 6
- Glutathione Transferases and Polymorphisms 4
- Chemical Synthesis and Analysis 3
- Receptor Mechanisms and Signaling 3
-
- Neuropeptides and Animal Physiology 3
- Co-authors
- Michael Mark (4 shared papers)Rolf Grempler (4 shared papers)Leo H. Thomas (2 shared papers)Frank Himmelsbach (2 shared papers)Matthias Eckhardt (2 shared papers)Achim Sauer (2 shared papers)Thomas Klein (2 shared papers)Dale E. Sharp (1 shared paper)
- Journals
- FEBS Letters (3 papers)European Journal of Biochemistry (2 papers)Diabetes Obesity and Metabolism (2 papers)Diabetologia (1 paper)Carcinogenesis (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Peter Eickelmann
19 papers receiving 1.1k citations
Peter Eickelmann's Hit Papers
Peers
Comparison fields: 5 of 81
- Endocrinology, Diabetes and Metabolism 516
- Toxicology 50
- Molecular Biology 580
- Surgery 299
- Nephrology 31
Countries citing papers authored by Peter Eickelmann
This map shows the geographic impact of Peter Eickelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Eickelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Eickelmann more than expected).
Fields of papers citing papers by Peter Eickelmann
This network shows the impact of papers produced by Peter Eickelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Eickelmann. The network helps show where Peter Eickelmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Eickelmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors Hit paper breakdown → | 2011 | 522 |
| 2 | 1997 | 140 | |
| 3 | 2011 | 68 | |
| 4 | 1994 | 49 | |
| 5 | 2003 | 48 | |
| 6 | 2011 | 45 | |
| 7 | 2003 | 33 | |
| 8 | 2012 | 32 | |
| 9 | Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase alpha messenger RNA in human renal cell carcinoma. | 1994 | 30 |
| 10 | 1994 | 30 | |
| 11 | 1991 | 29 | |
| 12 | 2002 | 27 | |
| 13 | 2013 | 26 | |
| 14 | 2007 | 12 | |
| 15 | 1996 | 12 | |
| 16 | 1996 | 8 | |
| 17 | 1995 | 8 | |
| 18 | 1995 | 2 | |
| 19 | 1995 | 1 |
About Peter Eickelmann
Peter Eickelmann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Physiology, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (6 papers), Pancreatic function and diabetes (4 papers), Glutathione Transferases and Polymorphisms (4 papers), Chemical Synthesis and Analysis (3 papers), Receptor Mechanisms and Signaling (3 papers), Diabetes Treatment and Management (3 papers), Neuropeptides and Animal Physiology (3 papers) and Adenosine and Purinergic Signaling (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (516 citations), Toxicology (50 citations), Molecular Biology (580 citations), Surgery (299 citations) and Nephrology (31 citations). Peter Eickelmann has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Michael Mark, Rolf Grempler, Leo H. Thomas, Frank Himmelsbach, Matthias Eckhardt, Achim Sauer, Thomas Klein, Dale E. Sharp, Remko A. Bakker and Helmut Sies. Their work appears in journals such as FEBS Letters, European Journal of Biochemistry, Diabetes Obesity and Metabolism, Diabetologia and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.